Technology update
Sep 17, 2007
Ultrasound nano-contrast lights up cancer
Nanoparticles are attracting considerable interest as disease-specific imaging contrast agents. Although most research work in this area has focused on magnetic resonance imaging, the case for developing a nanoparticle-based ultrasound contrast agent is growing. Researchers from Ohio State University in the US have now progressed this proposition a step further by showing that such an agent can improve the in vitro "echogenicity" of cancer cells.
We hope you've enjoyed the short summary of this article.
To continue reading, and for unlimited access to all content on this site
you will need to complete a short sign-up process.
It's free of charge, and will only take a couple of minutes of your time.
If you've signed up before, simply sign in below.
0 comments